{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:26:36Z","timestamp":1769300796803,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.trim.2025.102341","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:31:58Z","timestamp":1765326718000},"page":"102341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of induction agent selection on rejection, allograft function, and survival in kidney transplant recipients"],"prefix":"10.1016","volume":"94","author":[{"given":"Mohamad Saria","family":"Aldarwish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim","family":"Toomah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amro","family":"Idilbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roaa","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Hussam","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Alhalabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Alhassoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Mawaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Amir","family":"Balloura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Craver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tambi","family":"Jarmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2025.102341_bb0005","series-title":"The Banff 2019 Kidney Meeting Report (I): Updates on and Clarification of Criteria for T Cell\u2013And Antibody-Mediated Rejection","author":"Loupy","year":"2020"},{"issue":"1","key":"10.1016\/j.trim.2025.102341_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1172\/JCI93542","article-title":"Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection","volume":"128","author":"Chen","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.trim.2025.102341_bb0015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.kint.2021.11.029","article-title":"Allorecognition and the spectrum of kidney transplant rejection","volume":"101","author":"Callemeyn","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2025.102341_bb0020","series-title":"Heart Transplantation in Adults: Induction and Maintenance of Immunosuppressive Therapy","author":"Pham","year":"2021"},{"issue":"9117","key":"10.1016\/j.trim.2025.102341_bb0025","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0140-6736(05)77739-4","article-title":"Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients","volume":"351","author":"Calne","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.trim.2025.102341_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.13884","article-title":"Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?","volume":"17","author":"Hellemans","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2025.102341_bb0035","first-page":"17","article-title":"Humanized monoclonal antibody alemtuzumab treatment in transplant","volume":"14","author":"Bhowmick","year":"2016","journal-title":"Exp. Clin. Transpl."},{"issue":"1","key":"10.1016\/j.trim.2025.102341_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/11203990-000000000-00000","article-title":"Basiliximab: a review of its use as induction therapy in renal transplantation","volume":"24","author":"McKeage","year":"2010","journal-title":"BioDrugs"},{"issue":"6","key":"10.1016\/j.trim.2025.102341_bb0045","first-page":"373","article-title":"Basiliximab, mechanism of action and pharmacological properties","volume":"58","author":"Kapic","year":"2004","journal-title":"Med. Arh."},{"issue":"49","key":"10.1016\/j.trim.2025.102341_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036504","article-title":"Effect of basiliximab use on the risk of postoperative infection and death after heart transplantation: an observational study","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.trim.2025.102341_bb0055","first-page":"2","article-title":"SIMULECT- basiliximab injection, powder, for solution","author":"Medscape","year":"2025","journal-title":"DAILYMED"},{"issue":"4","key":"10.1016\/j.trim.2025.102341_bb0060","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ekir.2022.01.1042","article-title":"Thymoglobulin versus alemtuzumab versus Basiliximab kidney transplantation from donors after circulatory death","volume":"7","author":"Asderakis","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.trim.2025.102341_bb0065","article-title":"Older kidney transplant patients are over immunosuppressed using standard protocols with differential sex-based complications","volume":"2025","author":"Alshaer","year":"2025","journal-title":"J. Transp. Secur."},{"key":"10.1016\/j.trim.2025.102341_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2025.102198","article-title":"Induction outcomes in adult kidney transplantation: two decades of UNOS data analysis","volume":"89","author":"Aydin-Ghormoz","year":"2025","journal-title":"Transpl. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2025.102341_bb0075","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2215\/CJN.07540810","article-title":"Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States","volume":"6","author":"Gill","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.trim.2025.102341_bb0080","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/j.1600-6143.2005.01067.x","article-title":"Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction\u2014long-term results","volume":"5","author":"Kaufman","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2025.102341_bb0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5114\/ceji.2014.45955","article-title":"Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges","volume":"39","author":"Ebrahimi","year":"2014","journal-title":"Central Eur. J. Immunol."},{"key":"10.1016\/j.trim.2025.102341_bb0090","series-title":"The International Society of Heart and Lung Transplantation Guidelines for the Care of Heart Transplant Recipients","first-page":"914","author":"Costanzo","year":"2010"},{"issue":"8","key":"10.1016\/j.trim.2025.102341_bb0095","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1600-6143.2008.02299.x","article-title":"A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas\u2013kidney transplantation","volume":"8","author":"Magliocca","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102341_bb0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00003495-199957020-00006","article-title":"Basiliximab","volume":"57","author":"Sv","year":"1999","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.trim.2025.102341_bb0105","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2141.2005.05631.x","article-title":"Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease","volume":"130","author":"Schmidt-Hieber","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.trim.2025.102341_bb0110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bmt.1705306","article-title":"Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist","volume":"37","author":"Funke","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2025.102341_bb0115","series-title":"Transplantation Proceedings","article-title":"Basiliximab for the treatment of steroid-refractory acute graft-versus-host disease after unmanipulated HLA-mismatched\/haploidentical hematopoietic stem cell transplantation","author":"Wang","year":"2011"},{"issue":"2","key":"10.1016\/j.trim.2025.102341_bb0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/ejh.12691","article-title":"Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD 25 monoclonal antibody","volume":"97","author":"Chakupurakal","year":"2016","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.trim.2025.102341_bb0125","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41598-020-80567-9","article-title":"Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation","volume":"11","author":"L\u00f3pez-Abente","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trim.2025.102341_bb0130","series-title":"Transplantation Proceedings","article-title":"Basiliximab with delayed tacrolimus improves short-term renal outcomes post-liver transplantation\u2014A real-world experience","author":"Boyd","year":"2021"},{"issue":"4","key":"10.1016\/j.trim.2025.102341_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13813","article-title":"Economic impacts of alternative kidney transplant immunosuppression: a national cohort study","volume":"34","author":"Axelrod","year":"2020","journal-title":"Clin. Transpl."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:31:47Z","timestamp":1769257907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327425001698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"alternative-id":["S0966327425001698"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2025.102341","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of induction agent selection on rejection, allograft function, and survival in kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2025.102341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102341"}}